Market For COVID-19 Therapeutics Will Exceed Government Demand, US Believes
Executive Summary
HHS Secretary Azar says $1bn of the $2.5bn emergency supplemental funding request is for vaccine development.
You may also be interested in...
Buying The Coronavirus Vaccine: What Would A ‘Fair And Reasonable’ Price Be?
The US government has a routine approach for negotiating single-seller/single-buyer contracts, but drug pricing politics and public fears of coronavirus will likely complicate any purchasing talks with a sponsor, should an effective vaccine or therapeutic emerge.
Coronavirus May Boost Policy Efforts To Enhance US Drug, Medical Supply Production
Sen. Alexander says Congress should consider options to alleviate US dependence on other countries for drug and medical supply production once the outbreak subsides.
Coronavirus Knocks Drug Pricing Down – But Not Off – Political Priority List In US
When the top US health official testified before Congress on the budget this past week, drug pricing was barely discussed. What a difference two weeks – and global spread of a novel infectious disease – makes.